We are live on ! Find out more
IQMD

Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD

Delisted

IQMD was delisted on the 26th of April, 2023.

Back to rankings

57 hedge funds and large institutions have $151M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,850% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 2

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

185% more funds holding

Funds holding: 20 → 57 (+37)

110% more capital invested

Capital invested by funds: $71.9M → $151M (+$79.1M)

33.84% more ownership

Funds ownership: 31.31% → 65.15% (+34%)

Holders
57
Holders Change
+37
Holders Change %
+185%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
5
Reduced
1
Closed
2
Calls
$100K
Puts
–
Net Calls
+$100K
Net Calls Change
+$100K

Top Buyers

Rank Fund Capital Flow
1
MI
MMCAP International
Cayman Islands
+$9.93M
2
PC
Periscope Capital
Ontario, Canada
+$6.97M
3
LA
Linden Advisors
New York
+$6.95M
4
SC
Sculptor Capital
New York
+$4.97M
5
CSS
Cubist Systematic Strategies
Connecticut
+$4.24M

Top Sellers

Rank Fund Capital Flow
1
NAM
Nexpoint Asset Management
Texas
-$2.57M
2
HCM
Highbridge Capital Management
New York
-$2.25M
3
CS
Clear Street
New York
-$19K

IQMD Hedge Fund Activity: Q1 2022 in Review

57 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q1 2022, worth a combined $151M — up 110% from $71.9M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new IQMD positions and 2 closed out — a net gain of 37 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was MMCAP International, opening a new position worth an estimated $9.93M. The largest seller was Nexpoint Asset Management, exiting entirely with an estimated $2.57M sold.

  • 57 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q1 2022, up from 20 in Q4 2021.
  • Funds reported $151M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q1 2022, up 110% quarter-over-quarter.
  • 39 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q1 2022 and 2 closed out, a net change of +37 holders.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q1 2022 was MMCAP International, an estimated $9.93M added.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q1 2022 was Nexpoint Asset Management, an estimated $2.57M sold.

Based on aggregated 13F filings for Q1 2022.